According to OraSure Technologies's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.00479. At the end of 2023 the company had a P/S ratio of 1.49.
Year | P/S ratio | Change |
---|---|---|
2023 | 1.49 | 64.51% |
2022 | 0.9034 | -66.28% |
2021 | 2.68 | -39.42% |
2020 | 4.42 | 37.92% |
2019 | 3.21 | -18.58% |
2018 | 3.94 | -42.48% |
2017 | 6.85 | 79.38% |
2016 | 3.82 | 27.38% |
2015 | 3.00 | -44.01% |
2014 | 5.35 | 51.31% |
2013 | 3.54 | -21.75% |
2012 | 4.52 | -13.97% |
2011 | 5.25 | 48.28% |
2010 | 3.54 | 16.97% |
2009 | 3.03 | 27.57% |
2008 | 2.37 | -52.65% |
2007 | 5.01 | -10.03% |
2006 | 5.57 | -4.23% |
2005 | 5.82 | 4.81% |
2004 | 5.55 | -36.24% |
2003 | 8.71 | 34.26% |
2002 | 6.49 | -53.5% |
2001 | 14.0 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Quest Diagnostics
DGX | 1.61 | 60.65% | ๐บ๐ธ USA |
Cooper Companies COO | 4.82 | 379.43% | ๐บ๐ธ USA |
Trinity Biotech
TRIB | 0.2276 | -77.35% | ๐ฎ๐ช Ireland |
QuidelOrtho QDEL | 0.8848 | -11.94% | ๐บ๐ธ USA |
Chembio Diagnostics CEMI | 0.3457 | -65.60% | ๐บ๐ธ USA |
Bio-Rad Laboratories BIO | 2.95 | 193.50% | ๐บ๐ธ USA |